Objective To explore the generalizability and implementation effectiveness of standardized clinical pathways of food for special medical purpose (FSMP). Methods From November 10, 2023 to November 30, 2023, a pilot study for the standardized clinical pathway of FSMP in medical institutions was conducted at Nanjing Drum Tower Hospital (the Affiliated Hospital of Nanjing University Medical School), Chenzhou First People’s Hospital, and the Second People’s Hospital of Yibin. The hospitalized patients using FSMP in these three hospitals were continuously included to analyze the feasibility and effectiveness of the pathway. Results A total of 99 patients were included. The overall effect evaluation of the pathway showed that the proportion of convenient medical order (96.9%), timely delivery (100.0%), and easy storage (96.9%) were relatively high. The proportion of patients with good compliance was 88.9%, the proportion of patients who achieved treatment goals was 51.5%, and the proportion of patients who suspended the use of FSMP in advance was 19.2%. The incidence of gastrointestinal complications, metabolic complications, and infectious complications in patients were relatively low (<30%), and the median (lower quartile, upper quartile) satisfaction scores for patients, family members, and nurses were all 9.0 (8.0, 10.0) points. There was no statistically significant difference in the process evaluation indicators or satisfaction of FSMP clinical pathways between different prescribing personnel (P>0.05). There was no statistically significant difference in the process evaluation indicators or satisfaction of FSMP clinical pathways between different nutritional support methods (P>0.05). Conclusions The FSMP clinical pathway pilot has performed well in terms of convenience, compliance, satisfaction, with a low incidence of complications. The pathway is effective and safe, and can be widely applied.
Citation：
WANG Mengyan, GONG Jie, YU Fengmei, CHEN Muxi, CHEN Xiaotian, XU Dafeng, ZHENG Lihua, SHI Lei, RAO Zhiyong, HU Wen. Exploration and application of standardized clinical pathways of food for special medical purpose in medical institutions. West China Medical Journal, 2024, 39(12): 1905-1910. doi: 10.7507/1002-0179.202403088
Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
| 1. |
国家食品药品监督管理总局. 特殊医学用途配方食品注册管理办法. 北京: 国家食品药品监督管理总局, 2023.
|
| 2. |
|
| 3. |
|
| 4. |
湖北省卫生健康委员会. 关于印发《湖北省医疗机构特殊医学用途配方食品临床应用管理规范(试行)》的通知. 武汉: 湖北省卫生健康委员会, 2020.
|
| 5. |
江苏省市场监管局, 江苏省医疗保障局. 关于印发《江苏省特殊医学用途配方食品经营使用管理办法(试行)》的通知. 南京: 江苏省市场监管局, 2020.
|
| 6. |
Food Standards Australia New Zealand. Australia New Zealand food standards code standard 2.9.5 food for special medical purposes. Canberra: Food Standards Australia New Zealand, 2014.
|
| 7. |
|
| 8. |
|
| 9. |
南通市市场监督管理局. 关于进一步规范医疗机构经营使用特殊医学用途配方食品管理的通知. 南通: 南通市市场监督管理局, 2021.
|
| 10. |
安徽省市场监督管理局, 安徽省卫生健康委员会. 关于印发《安徽省特殊医学用途配方食品经营使用管理办法》的通知. 合肥: 安徽省市场监督管理局, 2023.
|
| 11. |
|
| 12. |
|
| 13. |
Dataintelo. Food for special medical purpose (FSMP) market outlook 2032. Pune: Dataintelo, 2024.
|
| 14. |
|
| 15. |
|
| 16. |
|
| 17. |
|
| 18. |
|
| 19. |
|
| 20. |
|
- 1. 国家食品药品监督管理总局. 特殊医学用途配方食品注册管理办法. 北京: 国家食品药品监督管理总局, 2023.
- 2.
- 3.
- 4. 湖北省卫生健康委员会. 关于印发《湖北省医疗机构特殊医学用途配方食品临床应用管理规范(试行)》的通知. 武汉: 湖北省卫生健康委员会, 2020.
- 5. 江苏省市场监管局, 江苏省医疗保障局. 关于印发《江苏省特殊医学用途配方食品经营使用管理办法(试行)》的通知. 南京: 江苏省市场监管局, 2020.
- 6. Food Standards Australia New Zealand. Australia New Zealand food standards code standard 2.9.5 food for special medical purposes. Canberra: Food Standards Australia New Zealand, 2014.
- 7.
- 8.
- 9. 南通市市场监督管理局. 关于进一步规范医疗机构经营使用特殊医学用途配方食品管理的通知. 南通: 南通市市场监督管理局, 2021.
- 10. 安徽省市场监督管理局, 安徽省卫生健康委员会. 关于印发《安徽省特殊医学用途配方食品经营使用管理办法》的通知. 合肥: 安徽省市场监督管理局, 2023.
- 11.
- 12.
- 13. Dataintelo. Food for special medical purpose (FSMP) market outlook 2032. Pune: Dataintelo, 2024.
- 14.
- 15.
- 16.
- 17.
- 18.
- 19.
- 20.
